- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05487105
Becoming a Parent During the COVID-19 Pandemic in Austria and Germany
August 2, 2022 updated by: Cristina Florea, University of Salzburg
Addendum Elternwerden in Zeiten Der COVID-19-Pandemie Zum Projekt "Pränatales Lernen Und Wiedererkennen Von Auditiven Reizen - Eine Psychophysiologische Perinatal Studie"
This is an online survey in Austria and Germany directed at parents with children born since the start of the first lockdown of the COVID-19 pandemic (birthdate beginning with 16.03.2020). The survey includes questions about:
- current stress levels and depressive symptoms,
- resilience during the pandemic,
- social support,
- retrospective birth risk factors, pregnancy distress and pregnancy experience,
- demographic factors and
- other questions related to parenting and the COVID-19 pandemic.
Study Overview
Status
Completed
Conditions
Detailed Description
The study evaluated data collected in the course of an online survey during the COVID-19 pandemic in Austria and Germany.
The questions were conceived to reflect aspects of pregnancy, childbirth and early child rearing that could be affected by the pandemic, and included commonly used and previously validated scores for assessing pregnancy distress (Pregnancy Distress Questionnaire, PDQ), birth experiences (Childbirth Experience Questionnaire 2, CEQ2) postnatal depression (Edinburgh Postnatal Depression Scale, EPDS), perceived stress (Perceived Stress Scale, PSS) and pandemic-related experiences (pandemic resilience part, adapted to postnatal period, from the Pandemic Related Stress in Pregnancy Scale, PREPS).
In addition, the investigators composed questions and scales that referred to specific pandemic- and parenting-related issues that were not covered otherwise.
The investigators also tried to question both the fathers and the mothers, and consequently mothers received more pregnancy-related questions than fathers.
Furthermore, biological mothers received childbirth-related questions which were omitted for adoptive mothers.
Study Type
Observational
Enrollment (Actual)
2226
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Salzburg, Austria, 5020
- Paris-Lodron University of Salzburg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Parents that had a baby born since the 16th of March 2020 (which corresponds to the beginning of the first lockdown in Austria and in Bavaria, Germany)
Description
Inclusion Criteria:
- parents that had a baby born since the 16th of March 2020 (which corresponds to the beginning of the first lockdown in Austria and in Bavaria, Germany)
- living in Austria or Germany
Exclusion Criteria:
- stillborn or neonatal death
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: Over the previous seven days from the time of answering the questionnaire
|
Score on the Edinburgh Postnatal Depression Scale, range 0-30.
Interpretation: 0-8 (depression not likely), 9-11 (depression possible), 12-13 (fairly high possibility), 14-30 (probable depression).
|
Over the previous seven days from the time of answering the questionnaire
|
|
Perceived stress
Time Frame: Over the previous month from the time of answering the questionnaire
|
Score on the Perceived Stress Scale, range 0 to 40.
Interpretation: 0-13 (low stress), 14-26 (moderate stress), 27-40 (high stress).
|
Over the previous month from the time of answering the questionnaire
|
|
Childbirth experience
Time Frame: At 0 to up to 15 months after birth (one assessment)
|
Score on the Childbirth Experience Questionnaire 2 - factors "Coping ability", "Participation" and "Emotional experience".
Range 13 (negative) to 52 (positive birth experience).
|
At 0 to up to 15 months after birth (one assessment)
|
|
Pregnancy distress
Time Frame: At 0 to up to 15 months after birth (one assessment)
|
Score on the Pregnancy Distress Questionnaire, 10 items scored from 0 to 4. The total score is the sum of all items divided by the number of items (10).
The score's range is 0 (low distress) to 4 (high distress).
|
At 0 to up to 15 months after birth (one assessment)
|
|
Resilience during the pandemic
Time Frame: One year after the beginning of the COVID-19 pandemic
|
Score on the resilience subscale from the Pandemic Related Pregnancy Stress Scale, adapted to postpartum participants.
It contains 7 items, scored from 1 to 5. The total score range is 7 (low resilience) to 35 (high resilience).
|
One year after the beginning of the COVID-19 pandemic
|
|
Social support
Time Frame: At 0 to up to 15 months after birth (one assessment)
|
The Social Support score consisted of 3 Items scored on a Likert scale from 0-4, covering the subjective feeling of social support.
Its possible range was 0 to 12, with higher scores indicating more social support.
|
At 0 to up to 15 months after birth (one assessment)
|
|
Child's Social Contacts
Time Frame: At 0 to up to 15 months after birth (one assessment)
|
The Child's Social Contacts score is the sum of frequencies with which the child has contact with other people, each item representing one person/relationship (mother, father, siblings, grandparents, other adults, other children), which are independent of each other.
The possible range for the Child's Social Contacts score was 0-6, 6 points indicating daily contact with parents, sibling(s), grandparent(s), other adults, and other children, and 0 indicating no contact at all.
|
At 0 to up to 15 months after birth (one assessment)
|
|
Pandemic Repercussions
Time Frame: One year after the beginning of the COVID-19 pandemic
|
The Pandemic Repercussions score comprises five items which inquire about the perceived influence of the coronavirus situation on the pregnancy, birth experience, health and development of the child, financial security, and on the partnership.
Each item was scored from -2 (for strong positive influence) to 2 (strong negative influence), making the possible range of the score from -10 to +10, where negative values indicate positive repercussions and positive values indicate negative repercussions.
|
One year after the beginning of the COVID-19 pandemic
|
|
Pandemic Distress
Time Frame: One year after the beginning of the COVID-19 pandemic
|
The Pandemic Distress score consisted of 3 Items that inquired about the participant's worries about the virus affecting herself, her relatives and/or her baby.
Each item was scored on a Likert scale from 0-4, so that the possible range of the score was 0-12, with higher values indicating that the participant is more worried.
This score is computed only for those participants who had not had Covid-19 themselves, since those who had had Covid-19 were not asked whether they worried to catch it again.
|
One year after the beginning of the COVID-19 pandemic
|
|
Birth Risk
Time Frame: Retrospectively assessed, at 0 to up to 15 months after birth (one assessment).
|
The Birth Risk score consists of 10 items which reflect the medical risk factors for a poor birth outcome: whether singleton or multiples pregnancy, pre/at/post-term birth, newborn weight at birth, type of birth, maternal age, quarantine during birth, history of miscarriage, mother's parity (higher risk if first or fifth/further pregnancy), length of hospitalization for the mother and for the baby.
This score had a possible range of 5 to 29, with lower values indicating smaller risk and higher values higher risk.
|
Retrospectively assessed, at 0 to up to 15 months after birth (one assessment).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlations between the scores from the primary outcome measures
Time Frame: At the time of answering the questionnaire
|
Spearman correlations between the scores from the primary outcome measures
|
At the time of answering the questionnaire
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Manuel Schabus, Prof. Dr., Paris-Lodron University of Salzburg
- Principal Investigator: Monika Angerer, Dr., Paris-Lodron University of Salzburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 18, 2021
Primary Completion (Actual)
July 1, 2021
Study Completion (Actual)
July 1, 2021
Study Registration Dates
First Submitted
July 29, 2022
First Submitted That Met QC Criteria
August 2, 2022
First Posted (Actual)
August 4, 2022
Study Record Updates
Last Update Posted (Actual)
August 4, 2022
Last Update Submitted That Met QC Criteria
August 2, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK-GZ12/2013-Addendum-07/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The anonymously collected data including the answers to the questionnaire, the questionnaire itself, and the analytic code shall be shared on an open data platform at the end of the study.
IPD Sharing Time Frame
The data will be uploaded by December 2022 and will be available for an unlimited time.
IPD Sharing Access Criteria
Researchers from accredited institutions.
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parents
-
Massachusetts General HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruiting
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterHackensack Meridian HealthActive, not recruiting
-
Holland Bloorview Kids Rehabilitation HospitalUniversity of TorontoUnknown
-
State University of New York - Upstate Medical...CompletedParentsUnited States
-
Seattle Children's HospitalNot yet recruitingParents | UsabilityUnited States
-
Chinese University of Hong KongNot yet recruiting
-
Northwestern UniversityDepartment of Health and Human ServicesCompletedChildren | ParentsUnited States
-
The University of Texas Medical Branch, GalvestonCompleted
-
Universidad de AlmeriaUniversitat Jaume IRecruiting